Resultados de búsqueda - ((((ligue OR sigue) OR line) OR (((lira OR (liman OR limas)) OR igar) OR laura)) OR ligule) 1

  1. 81
  2. 82

    Stereochemical preference toward oncotarget: Design, synthesis and <i>in vitro</i> anticancer evaluation of diastereomeric &#x3B2;-lactams por Olazarán Santibáñez, Fabián Eliseo, Bandyopadhyay, Debasish, Carranza Rosales, Pilar, Rivera, Gildardo, Balderas Rentería, Isaías

    Publicado 2017
    “…A cis-β-lactam [(±)-Cis3-amino-1-phenyl-4-(p-tolyl) azetidin-2-one, 6C] was found to be more active (in vitro) than the marketed natural drug colchicine against SiHa and B16F10 (six times higher potency) cell lines. …”
    Enlace del recurso
    Artículo
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89

    Interacción del complejo WT1-Par4 con el promotor P1 DE Bcl-2 en la línea celular MCF7 en presencia y ausencia de estímulo estrogénico por Hernández Herrera, Anadulce

    Publicado 2006
    “…In this work we propose to determinate the existence of a WT1-Par4 complex, its ability to bind the Bcl-2 promoter, and a possible relation with RE in the MCF7 cell line model, to aim it we used the cell culture, immunoprecipitation, Pull down and Western blot techniques. …”
    Enlace del recurso
    Tesis
  10. 90

    Interacción del complejo WT1-Par4 con el promotor P1 DE Bcl-2 en la línea celular MCF7 en presencia y ausencia de estímulo estrogénico por Hernández Herrera, Anadulce

    Publicado 2006
    “…In this work we propose to determinate the existence of a WT1-Par4 complex, its ability to bind the Bcl-2 promoter, and a possible relation with RE in the MCF7 cell line model, to aim it we used the cell culture, immunoprecipitation, Pull down and Western blot techniques. …”
    Enlace del recurso
    Tesis
  11. 91
  12. 92
  13. 93
  14. 94

    WT1 silencing by RNAi synergizes with chemotherapeutic agents and induces chemosensitization to doxorubicin and cisplatin in B16F10 murine melanoma cells por Zapata Benavides, Pablo, Manilla Muñoz, Edgar, Zamora Ávila, Diana Elisa, Saavedra Alonso, Santiago, Franco Molina, Moisés Armides, Trejo Ávila, Laura M., Dávalos Aranda, Guillermo, Rodríguez Padilla, Cristina

    Publicado 2012
    “…The objectives of this study were to investigate whether WT1 silencing is capable of synergizing with chemotherapeutic agents and whether this silencing is capable of sensitizing cancer cells to doxorubicin and cisplatin in the B16F10 murine melanoma cell line. …”
    Enlace del recurso
    Artículo
  15. 95
  16. 96
  17. 97
  18. 98

    Fármacos epigenéticos con efecto en la actividad promotora del gen rb1 en células hepáticas humanas por Vargas Gómez, Jorge Eduardo

    Publicado 2019
    “…Previously it was observed that the expression of RB1 was increased in the presence of the epigenetic drugs isotretinoin and thalidomide in the HepG2 cell line. …”
    Enlace del recurso
    Tesis
  19. 99

    Fármacos epigenéticos con efecto en la actividad promotora del gen rb1 en células hepáticas humanas por Vargas Gómez, Jorge Eduardo

    Publicado 2019
    “…Previously it was observed that the expression of RB1 was increased in the presence of the epigenetic drugs isotretinoin and thalidomide in the HepG2 cell line. …”
    Enlace del recurso
    Tesis
  20. 100

    WT1 shRNA delivery using transferrin-conjugated PEG liposomes in an in vivo model of melanoma por Saavedra Alonso, Santiago, Zapata Benavides, Pablo, Chávez Escamilla, Ana Karina, Manilla Muñoz, Edgar, Zamora Ávila, Diana Elisa, Franco Molina, Moisés Armides, Rodríguez Padilla, Cristina

    Publicado 2016
    “…Formulations of transferrin (Tf)‑conjugated polyethylene glycol (PEG) liposomes loaded with short hairpin RNA (shRNA) against WT1 (Lip + RNAi + Tf), PEG liposomes loaded with shRNA against WT1 (Lip + RNAi), Tf‑conjugated PEG liposomes loaded with pEGFP‑N3 (Lip + GFP + Tf) and saline solution as negative control (untreated) were administered systemically to C57BL/6 mice implanted subcutaneously with a melanoma cell line. …”
    Enlace del recurso
    Artículo

Herramientas de búsqueda: